| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |